AIG
IBB icon

American International Group’s iShares Biotechnology ETF IBB Stock Holding History

American International Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-54,027
Closed -$4.7M – 3682
2016
Q1 		$4.7M Buy
54,027
+2,958
+6% +$265K 0.02% 773
2015
Q4 		$5.76M Sell
51,069
-28,869
-36% -$3.13M 0.02% 648
2015
Q3 		$8.08M Buy
79,938
+6,312
+9% +$757K 0.04% 451
2015
Q2 		$9.06M Buy
73,626
+17,067
+30% +$2.04M 0.04% 425
2015
Q1 		$6.47M Sell
56,559
-7,215
-11% -$796K 0.03% 630
2014
Q4 		$6.45M Buy
63,774
+13,620
+27% +$1.32M 0.03% 602
2014
Q3 		$4.57M Buy
50,154
+15,171
+43% +$1.33M 0.02% 785
2014
Q2 		$3M Sell
34,983
-23,454
-40% -$1.85M 0.01% 961
2014
Q1 		$4.6M Buy
58,437
+10,626
+22% +$885K 0.02% 758
2013
Q4 		$3.62M Buy
47,811
+1,374
+3% +$97.5K 0.02% 847
2013
Q3 		$3.24M Buy
46,437
+8,001
+21% +$524K 0.02% 859
2013
Q2 		$2.23M Buy
+38,436
New +$2.22M 0.01% 1001

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
SG
Societe Generale $14.1B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

American International Group's IBB Position: Q2 2016 in Review

American International Group sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 54,027 shares — an estimated $4.7M sold.

American International Group first reported a position in IBB in Q2 2013 and held it in 12 quarters. The position peaked at $9.06M in Q2 2015. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

  • American International Group reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 54,027 iShares Biotechnology ETF shares in Q2 2016, an estimated $4.7M.
  • American International Group first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 12 quarters.
  • American International Group's iShares Biotechnology ETF position peaked at $9.06M in Q2 2015.
  • 429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.